Brief: Olema Oncology Announces Combined Financing For Up To $180 Mln
05/09/2023 12:33
Sept 5 (Reuters) - Olema Pharmaceuticals Inc OLMA.O :
* OLEMA ONCOLOGY ANNOUNCES COMBINED FINANCING FOR UP TO $180
MILLION
* OLEMA PHARMACEUTICALS INC - SENIOR SECURED CREDIT FACILITY
FOR
UP TO $50 MILLION PROVIDED BY SILICON VALLEY BANK
* OLEMA PHARMACEUTICALS INC - FINANCING PROVIDES SUFFICIENT
CAPITAL TO FUND OLEMA BEYOND OPERA-01 CLINICAL TRIAL TOP-LINE
DATA AND INTO 2027
Source text for Eikon: ID:nGNX7dkGpZ
Further company coverage: OLMA.O
((Reuters.briefs@thomsonreuters.com;))
Recent news on Olema Pharmaceuticals
See all newsOlema Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Olema Pharmaceuticals Q2 net loss widens on higher clinical trial spending
Brief: Olema Pharmaceuticals Q2 Net Income USD -63.2 Million
Brief: Olema Oncology Announces Clinical Trial Collaboration And Supply Agreement With Bayer To Evaluate Op-3136 In Combination With Nubeqa® (Darolutamide) In Metastatic Castration-Resistant Prostate Cancer
Olema Pharmaceuticals Q1 net loss widens on higher R&D costs